Comparison of Manuka Honey (Manuka Nd, G) and Etacridine Lactate (Rivanol) Applications in the Treatment of Infected Wounds in Cats

Authors

  • Nusret Apaydin Ebru Kemiksiz Department of Surgery, Faculty of Veterinary Medicine, University of Erciyes, Kayseri, Turkey.
  • Aytac Akcay Department of Surgery, Faculty of Veterinary Medicine, University of Erciyes, Kayseri, Turkey.

DOI:

https://doi.org/10.22456/1679-9216.90287

Abstract

Background: Ethacridine lactate (Rivanol) has been used as an antibacterial drug in the treatment of infected wounds for many years. Although Manuka honey has been used in the treatment of burns, ulcers and infected wounds in human medicine for many years, its use in veterinary medicine is new.  Manuka honey has been found to provide rapid cicatrization and lower chronic pain levels, to prevent bad odor, and has antibacterial properties. The aim of this study was to compare the effects of Etacridine lactate and Manuka honey in the treatment of infected wounds in cats.

Materials, Methods & Results:  In this study, 32 cats, with infected wounds in different areas on their body, were used. Cats were divided into two groups. The Rivanol group (n = 16) consisted of 6 female and 10 male cats aged 4 ± 3 years from different breeds and in several weights. Manuka group (n = 16) consisted of 7 male and 9 female cats of different breeds and weight and aged 4 ± 2 years. Rivanol was applied to the first group and Manuka honey (Manuka Nd, G) was applied to the second group. First measurements were recorded after the surgical debridement of the wound area. Four measurements were made every 3 days. The size (length - width) of the wounds was measured and recorded. Parenteral Marbofloxacin was administered orally in all cases. In order to prevent the contact of the cases with the dressing, the collar was worn. In the Rivanol group, when the first measurement values (length: 4.29 ± 2.78 cm, width: 2.13 ± 0.58 cm) and the 4th measurement values (length: 2.21 ± 1.37 cm, width: 1.06 ± 0.41 cm) were compared, there was a decrease in the wound size. In the Manuka group, when the first measurement values (length 2.84 ± 1.51 cm, width: 2.01 ± 1.03cm) and the 4th measurement values (length: 1.42 ± 1.10 cm, width: 0.90 ± 0.72cm) were compared, the wound sizes were diminished as in the Rivanol group. In all measurement days, the differences between of Rivanol and Manuka groups concerning the width, length and wound sizes were not statistically significant (P > 0.05). Wound size, length and width showed a linear decrease over the measurement days. These decreases were similar in Rivanol and Manuka group. There was no statistically significant difference between Rivanol (12.44 ± 3.74 days) and Manuka (12.44 ± 4.68 days) groups over the cicatrization period (P > 0.05).

Discussion: Rivanol and Manuka honey were effective in wound healing. Although there were no differences between the two groups, the wound sizes decreased in each measurement of the wounds. A moist environment was formed on the wound, debrideman accelerated and granulation tissue formation was encouraged with the application of both topical agents. Therefore, it was considered that wound healing in our cases was successful. It has been found that honey is frequently applied in wound treatment and in many areas in human medicine. However, in the field of veterinary medicine, there were few investigations. In the treatment of infected wounds of cats, it was determined that the application of Rivanol and Manuka honey yielded similar results in terms of time and there was no statistically significant difference. Manuka honey was found to be an alternative to Rivanol in the treatment of infected cat wounds. Manuka honey preparations (pad or pomade) were preferred because of the ease of use. In order to determine the efficacy of manuka honey in wound healing, it was thought that many further clinical or experimental studies should be carried out using microbiological, biochemical and histopathological parameters.

Downloads

Download data is not yet available.

References

Akın İ., Karademir Ü., Belge A., Balıkçı C. & Ural K. 2016. Marbofloxasin overdose: The culpritfor acute blindness in a dog. Kafkas Üniviversitesi Veteriner Fakültesi Dergisi. 22: 623-626.

Aron M., Akinpelu O.V., Gasbarrino K. & Daniel S.J. 2015. Safety of transtympanic application of %4 manuka honey in chinchilla animal model. European Archives of Otorhinolaryngology. 272(3): 537-542.

Bischofberger A.S., Dart C.M., Perkins N.R., Kelly A., Jeffcott L. & Dart A.J. 2013. The effect of short- and long-term treatment with manuka honey on second intention healing of contaminated and noncontaminated wounds on the distal aspect of the forelimbs in horses. Veterinary Surgery. 42(2): 154-160.

Burlango B. & Cornara L. 2013. Honey is dermatology and skin care: a review. Journal Cosmetic Dermatology. 12(4): 306-313.

Bugdanov S. 2016. Honey in Medicine, Chapter 9. In: Book of Honey. (Ed). Bee Product Science. pp. 4-9. [Fonte: <https://www.researchgate.net/publication/304011973>].

Bulman S.E.L., Tronci G., Goswami P., Carr C. & Russell SJ. 2017. Antibacterial Properties of Nonwoven Wound Dressing Coated with Manuka Honey or Methylgyloxal. Materials. 16(10): 1-14.

Cooper R. 2004. A review of the evidence for the use of topical antimicrobial agents in wound care. Wound Wide Wounds 2004; Revision 1.0. Available at <http://www.worldwidewounds.com/2004/february/Cooper/Topical-Antimicrobial-gents.html >. [Accessed online in September 2018].

Cooper R. 2016. Honey for wound care in the 21st century. Journal of Wound Care. 25(9): 544-552.

Cutting K.F. 2007. Honey and contemporary wound care: an overview. Ostomy Wound Management. 53(11): 49-54.

Dryden M., Lockyer G., Saeed K. & Cooke J. 2014. Engineered honey: In vitro antimicrobial activity of novel topical wound care treatment. Journal of Global Antimicrobial Resistance. 2(3): 168-172.

Fossum T.W. 2007. Small Animal Surgery. 3rd edn. St. Louis: Mosby-Year Book, pp.159-171.

Gentin G.T., Cowman S. & Conroy R.M. 2008. The impact of Manuka honey Dressings on the surface pH of chronic wounds. International Wound Journal. 5(2): 185-194.

Grego E., Robino P., Tramuta C., Giusto G., Boi M., Colombo R., Serra G., Chiado-Cutin S., Gandini M. & Nebbia P. 2016. Evaluation of antimicrobial activity of Italian honey for wound healing application in veterinary medicine. Gesellschaft Schweizer Tierärztinnen und Tierärzte GST. 158(7): 521-527.

Hixon K.R., Lu T., Carletta M.N., McBride-Gagyi S.H., Janowiak B.E. & Sell S.A. 2018. A preliminary in vitro evaluation of the bioactive potential of cryogel scaffolds incorporated with Manuka honey for the treatment of chronic bone infections. Journal Biomedical Materials Research Part B: Applied Biomaterials. 106(5): 1918-1933.

Junka A., Bartoszewicz M., Smutnicka D., Secewicz A. & Szymczyk P. 2013. Efficacy antiseptics containing povidone-iodine, octenidine dihydrochloride and ethacridine lactate aganist biofilm formed by Pseudomonas aeruginosa and Staphylococcus aureus measured with the novel biofilm-oriented antiseptics test. International Wound Journal. 11(6): 730-734.

Lee A. 2017. Degloving Wound and Medicinal Honey; VMSG 2017. Available at < http://www.vmsg.com/wp-content/uploads/2017/01/case-report-degloving-wound.pdf>. [Accessed online in July 2018].

McLoone P., Oluwadun A., Warnock M. & Fyfe L. 2016. Honey: A therapeutic agent for Disorders of the skin. Central Asian Journal of Global Health. 5(1): 241.

Molan P. 2001. Why honey is effective as a medicine. Bee World. 82(1): 22-40.

Molan P.C. 2001. Potential of honey in the treatment of wounds and burns. American Journal of Clinical Dermatology. 2(1): 13-19.

Mwipatayi B.P., Angel D., Hamilton M.J, Scott A. & Sieunarine K. 2004. The use of honey in chronic leg ulsers: A literature review. Primary Intention: The Australian Journal of Wound Management. 12(3): 107-112.

Niaz K., Maqbool F., Bahadar H. & Abdollahi M. 2017. Health Benefits of Manuka Honey as an Essential Constituent for Tissue Regenaration. Current Drug Metabolism. 18(10): 881-892.

Nicoara C.D., Singh M., Jester I., Reda B. & Parikh. 2014. Medicate Manuka honey in conservative management of exomphalos major. Pediatric Surgery International. 30(5): 515-520.

Paradis M., Abbey L., Baker B., Coyne M., Hannigan M., Joffe D., Pukay B., Trettien A., Waisglass S. & Wellington J. 2001. Evaluation of the clinical efficacy of marbofloxasin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial. Veterinary Dermatology 12: 163-169.

Simon A., Traynor K., Santos K., Blaser G., Bode U. & Molan P. 2009. Medical honey for wound care-still the ‘latest resort’? eCAM. 6(2): 165-173.

Taylor S. 2013. Manuka honey use for wound healing. School of Nursing online journal. Volume 1. [Fonte: < https://www.nursingjournal.co.nz/volume-one-2013/manuka-honey-use-for-wound-healing/ >].

Tramuta C., Nebbia P., Robino P., Giusto G., Gandini M., Chiado-Cutin S. & Grego E. 2017. Antibacterial activities of Manuka and Honeydew honey-based membranes against bacteria that cause wound infections in animals. Schweiz Arch Tierheilkd. 159(2): 117-121.

Willix D.J., Molan P.C. & Harfoo C.G. 1992. A comparison of sensivity of wound infecting species of bacteria to the antibacterial activity of manuka honey and other honey. Journal of Applied Bacteriology. 73(5): 388-394.

Published

2019-01-01

How to Cite

Kemiksiz, N. A. E., & Akcay, A. (2019). Comparison of Manuka Honey (Manuka Nd, G) and Etacridine Lactate (Rivanol) Applications in the Treatment of Infected Wounds in Cats. Acta Scientiae Veterinariae, 47(1). https://doi.org/10.22456/1679-9216.90287

Issue

Section

Articles